Actelion Pharmaceuticals US

Actelion Pharmaceuticals US is a biopharmaceutical company dedicated to the discovery, development, and commercialization of low molecular weight drugs for various medical needs. Its key products include Tracleer, an orally administered dual endothelin receptor antagonist approved for the treatment of pulmonary arterial hypertension (PAH).